We are live on ! Find out more
Korea Investment Corp

Korea Investment Corp Portfolio holdings

AUM $48.3B
1-Year Est. Return 31.57%
This Fund
S&P 500
This Quarter Est. Return
+10.62%
1 Year Est. Return
+31.57%
3 Year Est. Return
+108.38%
5 Year Est. Return
+144.09%
10 Year Est. Return
+570.78%
AUM
$34.3B
AUM Growth
+$2.51B
Cap. Flow
+$180M
Cap. Flow %
0.53%
Top 10 Hldgs %
24.04%
Holding
762
New
11
Increased
290
Reduced
432
Closed
10

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$55.3M
2
ACN icon
Accenture
ACN
+$45.2M
3
UNP icon
Union Pacific
UNP
+$44.6M
4
ADP icon
Automatic Data Processing
ADP
+$41.5M
5
CVX icon
Chevron
CVX
+$41.3M

Sector Composition

Rank Sector Weight
1 Technology 26.78%
2 Healthcare 13.13%
3 Financials 12.57%
4 Consumer Discretionary 9.99%
5 Industrials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
676
Teva Pharmaceuticals
TEVA
$42.3B
$1.87M 0.01%
210,993
-51,385
-20% -$508K
EPOL icon
677
iShares MSCI Poland ETF
EPOL
$821M
$1.85M 0.01%
119,474
ICL icon
678
ICL Group
ICL
$6.89B
$1.85M 0.01%
275,709
+10,973
+4% +$81K
KMX icon
679
CarMax
KMX
$8.32B
$1.83M 0.01%
28,411
-10,369
-27% -$694K
PLTR icon
680
Palantir
PLTR
$421B
$1.8M 0.01%
212,670
-58,189
-21% -$455K
FCNCA icon
681
First Citizens BancShares
FCNCA
$25.4B
$1.78M 0.01%
1,830
-3,524
-66% -$2.62M
LUV icon
682
Southwest Airlines
LUV
$22.4B
$1.76M 0.01%
54,128
+3,364
+7% +$114K
IVZ icon
683
Invesco
IVZ
$13.9B
$1.74M 0.01%
106,135
-30,873
-23% -$551K
DSGX icon
684
Descartes Systems
DSGX
$6.8B
$1.72M 0.01%
21,347
+577
+3% +$43K
TPL icon
685
Texas Pacific Land
TPL
$25.1B
$1.72M 0.01%
9,090
-20,259
-69% -$4.22M
ARMK icon
686
Aramark
ARMK
$16B
$1.69M ﹤0.01%
65,393
-13,528
-17% -$385K
NBIX icon
687
Neurocrine Biosciences
NBIX
$16.5B
$1.67M ﹤0.01%
16,546
-1,879
-10% -$196K
MPT
688
Medical Properties Trust
MPT
$2.4B
$1.66M ﹤0.01%
201,656
-199,414
-50% -$2.2M
ELAN icon
689
Elanco Animal Health
ELAN
$11.3B
$1.64M ﹤0.01%
174,557
-55,093
-24% -$650K
HEI icon
690
HEICO Corp
HEI
$51B
$1.62M ﹤0.01%
9,443
-3,284
-26% -$553K
AZPN
691
DELISTED
Aspen Technology Inc
AZPN
$1.59M ﹤0.01%
6,962
-1,782
-20% -$370K
NVCR icon
692
NovoCure
NVCR
$2.05B
$1.59M ﹤0.01%
26,377
-7,986
-23% -$638K
ERIE icon
693
Erie Indemnity
ERIE
$13.5B
$1.58M ﹤0.01%
6,822
+9
+0.1% +$2.15K
EMN icon
694
Eastman Chemical
EMN
$8.54B
$1.58M ﹤0.01%
18,689
-6,879
-27% -$591K
FFIV icon
695
F5
FFIV
$23.5B
$1.54M ﹤0.01%
10,540
-18,136
-63% -$2.62M
UHAL.B icon
696
U-Haul Holding Co Series N
UHAL.B
$12.5B
$1.47M ﹤0.01%
28,372
-2,369
-8% -$134K
WB icon
697
Weibo
WB
$1.93B
$1.47M ﹤0.01%
73,150
+1,000
+1% +$20.5K
VTRS icon
698
Viatris
VTRS
$18.6B
$1.41M ﹤0.01%
146,377
-63,319
-30% -$702K
ROKU icon
699
Roku
ROKU
$22.4B
$1.39M ﹤0.01%
21,180
-48,372
-70% -$2.83M
LEGN icon
700
Legend Biotech
LEGN
$4.27B
$1.38M ﹤0.01%
28,690
-3,000
-9% -$147K

Similar funds

Korea Investment Corp's Q1 2023 Portfolio in Review

As of Q1 2023, Korea Investment Corp held 762 positions worth $34.3B, up 7.9% from $31.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.8%. Korea Investment Corp opened 11 new positions and exited 10, leaving the 762-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Korea Investment Corp's largest Q1 2023 buy was Vanguard S&P 500 ETF: 461,934 shares worth $174M.
  • Korea Investment Corp added most to iShares Core S&P 500 ETF in Q1 2023, an estimated $169M increase.
  • Korea Investment Corp's biggest Q1 2023 reduction was Linde, cutting an estimated $55.3M.
  • Korea Investment Corp fully exited Signature Bank in Q1 2023, selling an estimated $10.6M.
  • Korea Investment Corp's ten largest holdings make up 24% of its $34.3B portfolio in Q1 2023.
  • Korea Investment Corp opened 11 new positions and closed 10 in Q1 2023.
  • Korea Investment Corp's portfolio value rose 7.9% quarter-over-quarter to $34.3B.

Based on Korea Investment Corp's 13F filing for Q1 2023, filed 12 May 2023.